Press Room

Find news and updates from PhRMA, representing the country’s leading biopharmaceutical research companies. Our members are committed to finding tomorrow’s cures and treatments for some of the most serious diseases such as cancer, Alzheimer’s disease, cystic fibrosis and Parkinson’s.

Latest News from PhRMA

Biopharmaceuticals Support 4.5M Jobs and $1.2T Output

May 16, 2016

The biopharmaceutical industry supported nearly 854,000 direct jobs and more than $1.2 trillion in economic output in 2014.

Read More

Miembros de PhRMA Invirtieron $58,8 Billones en I&D

May 12, 2016

Las compañías miembros de PhRMA invirtieron aproximadamente $58,8 billones en I&D en el año 2015.

Read More

PhRMA Member Companies Invested $58.8 Billion in 2015 R&D

May 11, 2016

PhRMA member companies invested an estimated $58.8 billion in research and development (R&D) in 2015.

Read More

More Than 560 Medicines in Development for Rare Diseases

May 6, 2016

A new report reveals that America’s biopharmaceutical research companies are currently developing more than 560 medicines for patients with rare diseases.

Read More

Lauren Levinson Named PhRMA V.P. of Communications

April 29, 2016

As Vice President of Communications, Lauren Levinson will help craft the association’s communications strategy and public positioning.

Read More

PhRMA Statement on 2016 Special 301 Report

April 27, 2016

Vice President Jay Taylor issues a statement on Special 301, a tool to bring attention to intellectual property and market access challenges in overseas markets.

Read More

CSRxP Offers Can Harm Competitive Market & Patients

April 25, 2016

PhRMA Senior Vice President Robert Zirkelbach released a statement in response to the Campaign for Sustainable Rx Pricing’s proposals.

Read More

PhRMA Statement on MedPAC April Recommendations and Vote

April 7, 2016

PhRMA strongly opposes the sweeping new Medicare Part D recommendations approved by MedPAC.

Read More

Statement on Workforce Authorities Modernization Act

March 17, 2016

PhRMA issued a statement on the FDA and NIH Workforce Authorities Modernization Act.

Read More

Biogen CEO George A. Scangos Becomes PhRMA Board Chairman

March 10, 2016

George A. Scangos, CEO of Biogen, was elected chairman of the PhRMA board. Scangos formerly held the position of chairman-elect.

Read More